Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
- 期刊名称Pharmacology & Therapeutics
- 作者Wagner, Karen M.; McReynolds, Cindy B.; Schmidt, William K.; Hammock, Bruce D.
- 印刷ISSN0163-7258
- 文件大小853.37KB
- 发表时间2017-6
- DOI10.1016/j.pharmthera.2017.06.006
MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagusHezova, Renata; Kovarikova, Alena; Srovnal, Josef; Zemanova, Milada; Harustiak, Tomas; Ehrmann, Jiri; Hajduch, Marian; Sachlova, Milana; Svoboda, Marek; Slaby, Ondrej · Tumor Biology · 2015
Response to Definitive Chemoradiotherapy and Survival in Patients with an Oesophageal Adenocarcinoma versus Squamous Cell Carcinoma: A Matched-Pair AnalysisTougeron, David; Di Fiore, Frédéric; Hamidou, Hadji; Rigal, Olivier; Paillot, Bernard; Michel, Pierre · Oncology · 2007
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 studyMelichar, Bohuslav; Adenis, Antoine; Lockhart, A Craig; Bennouna, Jaafar; Dees, E Claire; Kayaleh, Omar; Obermannova, Radka; DeMichele, Angela; Zatloukal, Petr; Zhang, Bin; Ullmann, Claudio Dansky; Schusterbauer, Claudia · The Lancet Oncology · 2015